The intracutaneous pain model in the assessment of analgesic efficacy

Pain Reviews

Volumn 5, Issue 4, 1998, Pages 216-246

  Scharein, Eckehard ^a   Bromm, Burkhart ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANPIRTOLINE; DENAVERINE; DICLOFENAC; FLUPIRTINE; IBUPROFEN; IMIPRAMINE; KETAMINE; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENTAZOCINE; PETHIDINE; PHENAZONE; TILIDINE; TRAMADOL; VALORON N;

ANALGESIA; BRAIN CORTEX; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EVOKED CORTICAL RESPONSE; HUMAN; HUMAN EXPERIMENT; INTRACUTANEOUS TEST; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NOCICEPTION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PAIN; PAIN ASSESSMENT; REVIEW; SELF EVALUATION; SKIN NERVE; STIMULUS RESPONSE;

EID: 0032406588     PISSN: 09681302     EISSN: None     Source Type: Journal    
DOI: 10.1191/096813098674115417     Document Type: Review

References (164)

1. Merskey H. The definition of pain. Eur J Psychiatry 1991; 6: 153-59.
2. Anand KJS, Craig KD. New perspectives on the definition of pain. Pain 1996; 67: 3-6.
3. Melzack R, Katz J. Pain measurement in persons in pain. In: Wall PD, Melzack R eds. Textbook of pain. Edinburgh: Churchill Livingstone, 1995; 337-51.
4. Beecher H. Measurement of subjective responses. Quantitative effects of drugs. New York: Oxford University Press, 1959.
5. Willis WD. From nociceptor to cortical activity. In: Bromm B, Desmedt J eds. Pain and the brain: from nociception to cognition. New York: Raven, 1995: 1-20.
6. Carstens E. Neural mechanisms of hyperalgesia: peripheral or central sensitization? News Physiol Sci 1995; 10: 260-65.
7. Munglani R, Hunt SP. Molecular biology of pain. Br J Anaesth 1995; 75: 186-82.
8. Flor H, Braun C, Elbert T, Birbaumer N. Extensive reorganization of primary somatosensory cortex in chronic back pain patients. Neurosci Lett 1997; 224: 5-8.
9. Birbaumer N, Flor H, Lutzenberger W, Elbert T. The corticalization of chronic pain. In: Bromm B, Desmedt J eds. Pain and the brain: from nociception to cognition. New York: Raven, 1995: 331-44.
10. Bromm B. Corticalisation of pain. Am Pain Soc J 1994; 3: 131-35.
11. Wall PD, Melzack R eds. Textbook of pain. Edinburgh: Churchill Livingstone, 1995.
12. Bromm B, Desmedt J eds. Pain and the brain: from nociception to cognition. New York: Raven, 1995.
13. Le Bars D, Bouhassira D, Villanueva L. Opioids and diffuse noxious inhibitory control (DNIC) in the rat. In: Bromm B, Desmedt J eds. Pain and the brain: from nociception to cognition. New York: Raven, 1995: 517-39.
14. Zacny JP, Lichtor JL, Thapar P, Coalson DW, Flemming D, Thompson WK. Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers. J Pharmacol Exp Ther 1994; 270: 579-88.
15. Meert TF. Pharmacotherapy of opioids: present and future developments. Pharm World Sci 1996; 18: 1-15.
16. Zieglgänsberger W, Tölle TR, Zimprich A, Höllt V, Spanagel R. Endorphins, pain relief, and euphoria. In: Bromm B, Desmedt J eds. Pain and the brain: from nociception to cognition. New York: Raven, 1995: 439-58.
17. Vallbo AB, Hagbarth KE, Torebjoerk HE, Wallin BG. Somatosensory, proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev 1979; 59: 919-57.
18. Torebjoerk HE, Hallin RG. Skin receptors supplied by unmyelinated (C) fibres in man. In: Zottermann Y ed. Sensory function of the skin in primates. Oxford: Pergamon, 1976: 475-87.
19. Handwerker HO, Adriaensen HFM, Gybels JM, Van Hees J. Nociceptor discharges and pain sensations: results and open questions. In: Bromm B ed. Pain measurement in man: neurophysiological correlates of pain. Amsterdam: Elsevier, 1984: 55-64.
20. 2 laser stimuli causing pain. Exp Brain Res 1984; 55: 158-71.
21. Sicuteri F, Del Bene E, Poggioni M. Changes of vegetative parameters under pain. In: Bromm B ed. Pain measurement in man: neurophysiological correlates of pain. Amsterdam: Elsevier, 1984: 111-26.
22. Handwerker HO, Kobal G. Psychophysiology of experimentally induced pain. Physiol Rev 1993; 73: 639-71.
23. Willer JC, Le Bars D. Electrophysiologic studies on morphine analgesia in humans. In: Bromm B, Desmedt J eds. Pain and the brain: from nociception to cognition. New York: Raven, 1995: 541-57.
24. Bromm B ed. Pain measurement in man: neurophysiological correlates of pain. Amsterdam: Elsevier, 1984.
25. Zbinden AM, Maggiorni M, Petersen-Felix S, Thomson DA, Minder CE. Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia. Anesthesiology 1994; 80: 253-60.
26. Heier T, Steen PA. Assessment of anaesthesia depth. Acta Anaesthesiol Scand 1996; 40: 1087-100.
27. Deutschman CS, Harris AP, Fleisher LA. Changes in heart rate variability under propofol anesthesia: a possible explanation for propofol-induced bradycardia. Anesth Analg 1994; 79: 373-77.
28. Franklin KBJ, Abbott FV. Techniques for assessing the effects of drugs on nociceptive responses. In: Boulton AA, Baker GB, Greenshaw AJ eds. Psychopharmacology. Clifton, NJ: Humana Press, 1989: 145-216.
29. Hammond D. Inference of pain and its modulation from simple behavior. In: Chapman CR, Loeser JD eds. Issues in pain measurement. New York: Raven, 1989: 69-92.
30. Bromm B. Pain-related components in the cerebral potential. Experimental and multivariate statistical approaches. In: Bromm B ed. Pain measurement in man: neurophysiological correlates of pain. Amsterdam: Elsevier, 1984: 233-56.
31. Bromm B. Evoked cerebral potential and pain. In: Fields HL, Dubner R, Cervero F eds. Proceedings of the IVth World Congress on Pain (Advances in pain research and therapy, vol. 9); 1984 Aug 31-Oct 5; Seattle. New York: Raven Press, 1985: 305-29.
32. Bromm B. Laboratory animals and human volunteers in the assessment of analgesic efficacy. In: Chapman CR, Loeser JD eds. Issues in pain measurement. New York: Raven, 1989: 117-43.
33. Bromm B, Meier W. The intracutaneous stimulus: a new pain model for algesimetric studies. Methods Find Exp Clin Pharmacol 1984; 6: 405-10.
34. Droste C, Greenlee MW, Schreck M, Roskamm H. Experimental pain thresholds and plasma beta-endorphin levels during exercise. Med Sci Sports Exerc 1991; 23: 334-42.
35. Joseph J, Howland EW, Wakai R, Backonja M, Baffa O, Potenti FM. Late pain-related magnetic fields and electric potentials evoked by intracutaneous electric finger stimulation. Electroencephalogr Clin Neurophysiol 1991; 80: 46-52.
36. Miltner W, Johnson R, Braun C, Larbig W. Somatosensory event-related potentials to painful and non-painful stimuli: effects of attention. Pain 1989; 38: 303-12.
37. Flor H, Elbert T, Knecht S et al. Phantom-limb pain as a perceptual correlate of cortical reorganization following arm amputation. Nature 1995; 375: 482-84.
38. Howland EW, Wakai RT, Mjaanes BA, Balog JP, Cleeland CS. Whole head mapping of magnetic fields following painful electric shock. Cogn Brain Res 1995; 2: 165-72.
39. Hardy JF, Wolff HG, Goodell H. Pain sensation and reactions. Baltimore, MD: Williams and Wilkins, 1952.
40. Mountcastle VB. Pain and temperature sensibilities. In: Mountcastle VB ed. Medical physiology. St Louis, MD: Mosby, 1980: 391-427.
41. Campbell IG, Carstens E, Watkins LR. Comparison of human pain sensation and flexion withdrawal evoked by noxious radiant heat. Pain 1991; 45: 259-68.
42. Casey KL, Minoshima S, Morrow TJ, Koeppe RA. A comparison of human cerebral activation patterns during cutaneous warmth, heat pain and deep cold pain. J Neurophysiol 1996; 76: 571-81.
43. Wolf S, Hardy JD. Studies on pain. Observations on pain due to local cooling and on factors involved in the 'cold pressor' effect. J Clin Invest 1941; 20: 521-33.
44. Peckerman A, Hurwitz BE, Saab PG, Llabre MM, McCabe PM, Schneiderman N. Stimulus dimensions of the cold pressor test and the associated patterns of cardiovascular response. Psychophysiology 1994; 31: 282-90.
45. Chen ACN, Treede R, Bromm B. Modulation of pain evoked cerebral potential by concurrent subacute pain. In: Bromm B ed. Pain measurement in man: neurophysiological correlates of pain. Amsterdam: Elsevier, 1984: 301-309.
46. Janal MN, Clark WC, Carroll JD. Multidimensional scaling of painful electrocutaneous stimulation: INDSCAL dimensions, signal detection theory indices, and the McGill Pain Questionnaire. Somatosens Mot Res 1993; 10: 31-39.
47. Lim RS, Guzman F. Manifestations of pain in analgesic evaluation in animals and man. In: Soulairac A, Cahn J, Charpentier J eds. Pain. New York: Academic Press, 1968: 119-52.
48. Simone DA, Baumann TK, LaMotte RH. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 1989; 38: 99-107.
49. Veerasarn P, Stohler CS. The effect of experimental muscle pain on the background electrical brain activity. Pain 1992; 49: 349-60.
50. Lynn B, Perl ER. A comparison of four tests for assessing the pain sensitivity of different subjects and test area. Pain 1977; 3: 353-65.
51. Anton F, Kreh A, Reeh PW, Handwerker HO. Algesimetry using natural stimuli of long duration. In: Bromm B ed. Pain measurement in man. Amsterdam: Elsevier, 1984: 455-62.
52. Koltzenburg M, Handwerker HO. Differential ability of human cutaneous nociceptors to signal mechanical pain and to produce vasodilatation. J Neurosci 1994; 14: 1756-65.
53. Bromm B, Scharein E. Principal component analysis of pain-related cerebral potentials to mechanical and electrical stimulation in man. Electroencephalogr Clin Neurophysiol 1982; 53: 94-103.
54. Stowell H. Event related brain potentials and human pain: a first objective overview. Int J Psychophysiol 1984; 1: 137-51.
55. Buchsbaum MS. Quantification of analgesic effects by evoked potentials. In: Bromm B ed. Pain measurement in man: neurophysiological correlates of pain. Amsterdam: Elsevier, 1984: 291-300.
56. Becker DE, Yingling CD, Fein G. Identification of pain, intensity and P300 components in the pain evoked potential. Electroencephalogr Clin Neurophysiol 1993; 88: 290-301.
57. Dowman R. SEP topographies elicited by innocuous and noxious sural nerve stimulation. 2: Effects of stimulus intensity on topographic pattern and amplitude. Electroencephalogr Clin Neurophysiol 1994; 92: 303-15.
58. Kakigi R, Koyama S, Hoshiyama M, Shimojo M, Kitamura Y, Watanabe S. Topography of somatosensory evoked magnetic fields following posterior tibial nerve stimualtion. Electroencephalogr Clin Neurophysiol 1995; 95: 127-34.
59. Yamamoto M, Kachi T, Igata A. Pain-related and electrically stimulated somatosensory evoked potentials in patients with stroke. Stroke 1995; 26: 426-29.
60. Chatrian GE, Canfield RC, Knauss TA, Lettich E. Cerebral responses to electrical toothpulp stimulation in man. Neurology 1975; 25: 747-57.
61. Chapman CR, Jacobson RC. Assessment of analgesic states: can evoked potentials play a role? In: Bromm B ed. Pain measurement in man. Amsterdam: Elsevier, 1984: 233-56.
62. Klement W, Medert HA, Arndt JO. Nalbuphine does not act analgetically in electrical painful tooth pulp stimulation in man. Pain 1992; 48: 269-74.
63. Lekic D, Cenic D. Pain and tooth pulp evoked potentials. Clin Electroencephalogr 1992; 23: 37-46.
64. Suri A, Kaltenbach ML, Grundy BL, Derendorf H. Pharmacodynamic evaluation of codeine using tooth pulp evoked potentials. J Clin Pharmacol 1996; 36: 1126-31.
65. Carmon A, Mor J, Goldberg J. Evoked responses to noxious thermal stimulations. Exp Brain Res 1976; 25: 103-107.
66. 2 laser stimulation in man. Electroencephalagr Clin Neurophysiol 1989; 74: 139-46.
67. Bromm B, Treede R. Laser evoked cerebral potentials in the diagnosis of cutaneous pain sensitivity. Rev Neurol 1991; 147: 625-43.
68. Arendt-Nielsen L. Characteristics, detection, and modulation of laser-evoked vertex potentials. Acta Anaesthesiol Scand 1994; 38: 5-44.
69. Kazarians H, Scharein E, Bromm B. Laser-evoked brain potentials in response to painful trigeminal nerve activation. Int J Neurosci 1998; 81: 111-22.
70. Lorenz J, Hansen C, Kunze K, Bromm B. Sensory deficits of a nerve root lesion can be objectively documented by somatosensory evoked potentials elicited by painful infrared laser stimulation. J Neurol Neurosurg Psychiatry 1996; 61: 107-10.
71. 2 laser stimulation in man. Electroencephalogr Clin Neurophysiol Evoked Potentials 1996; 100: 105-14.
72. Munger BL, Halata Z. The sensory innervation of primate facial skin. Brain Res Rev 1983; 5: 45-80.
73. Chen ACN, Treede RD. The McGill Pain Questionnaire in the assessment of phasic and tonic experimental pain: behavioral evaluation of the 'pain inhibiting pain' effect. Pain 1985; 22: 67-79.
74. Colon EJ, Comi G. Long latency somatosensory evoked potentials. In: Colon EJ, Viser SL eds. Evoked potentials: a practical guide to clinical applications. Dordrecht: Academic, 1990: 279-306.
75. Nuwer MR, Lehmann D, Dasilva FL, Matsuoka S, Sutherling W, Vibert JF. IFCN guidelines for topographic and frequency analysis of EEGs and EPs. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 1994; 91: 1-5.
76. Adriaensen H, Gybels J, Handwerker HO, Van Hees J. Response properties of thin myelinated (A-delta) fibers in human skin nerves. J Neurophysiol 1983; 49: 111-22.
77. Swerup C. Determination of conduction velocity in A-delta and C fibres in humans from thermal thresholds. Acta Physiol Scand 1995; 153: 81-82.
78. Bromm B, Lorenz J. Neurophysiological evaluation of pain: a review. Electroencephalogr Clin Neurophysiol 1998 (in press).
79. Jasper HH. The ten-twenty system of the International Federation. Electroencephalogr Clin Neurophysiol 1958; 80: 46-52.
80. Angel RW, Quick WM, Boylls CC, Weinrich M, Rodnitzky RL. Decrement of somatosensory evoked potentials during repetitive stimulation. Electroencephalogr Clin Neurophysiol 1985; 60: 335-42.
81. Picton T, Hillyard S. Endogenous event-related potentials. In: Picton T ed. Human event-related potentials: handbook of electroencephalography and clinical neurophysiology, vol. 3. Amsterdam: Elsevier, 1988: 361-462.
82. Desmedt JE. Somatosensory evoked potentials. In: Picton TW ed. Human event-related potentials: handbook of electroencephalography and neurophysiology, vol. 3. Amsterdam: Elsevier, 1988: 85-130.
83. Bromm B, Neitzel H, Tecklenburg A, Treede RD. Evoked cerebral potential correlates of C-fibre activity in man. Neurosci Lett 1983; 43: 109-14.
84. Bromm B, Treede RD. Pain related cerebral potentials: late and ultralate components. Int Neurosci 1987; 33: 15-23.
85. 2 laser stimulation of tiny cutaneous surface areas in man. Neurosci Lett 1996; 209: 81-84.
86. Yamaguchi S, Tsuchiya H, Kobayashi S. Electroencephalographic activity associated with shifts of visuospatial attention. Brain 1994; 117: 553-62.
87. Hohnsbein J, Falkenstein M, Hoorman J, Blanke L. Effects of crossmodal divided attention on late ERP components. I: Simple and choice reaction task. Electroencephalogr Clin Neurophysiol 1991; 78: 438-16.
88. Mecklinger A, Ullsperger P, Moelle M, Grune K. Event-related potentials indicate information extraction in a comparative judgement task. Psychophysiology 1994; 31: 23-28.
89. Martinloeches M, Barcelo F, Rubia FJ. Sources and topography of supramodal effects of spatial attention in ERP. Brain Topogr 1997; 10: 9-22.
90. Miron D, Duncan GH, Bushnell MC. Effects of attention on the intensity and unpleasantness of thermal pain. Pain 1989; 39: 345-52.
91. Eccleston C. The attentional control of pain: methodological and theoretical concerns. Pain 1995; 63: 3-10.
92. Guest GH, Drummond PD. Effect of compensation on emotional state and disability in chronic back pain. Pain 1992; 48: 125-30.
93. Janssen SA, Arntz A. Anxiety and pain: attentional and endorphinergic influences. Pain 1996; 66: 145-50.
94. Edwards LC, Pearce SA, Turner-Stokes L, Jones A. The Pain Beliefs Questionnaire: an investigation of beliefs in the causes and consequences of pain. Pain 1992; 51: 267-72.
95. Bromm B, Scharein E. Response plasticity of pain evoked reactions in man. Physiol Behav 1982; 28: 109-16.
96. Fahrenberg J, Selg H. Freiburger Persönlichkeitsinventar (FPI). Göttingen: Hogrefe Verlag, 1979.
97. Strian F, Lautenbacher S, Galfe G, Hoelzl R. Diurnal variations in pain perception and thermal sensitivity. Pain 1989; 36: 125-31.
98. Druera E, Macmillan K, Kuehn N, Miller MJ. Circadian distribution of extra doses of narcotic analgesics in patients with cancer pain: a preliminary report. Pain 1992; 49: 311-14.
99. Morawetz RF, Parth P, Pöppel P. Influence of the pain measurement technique on the diurnal variation of pain perception. In: Bromm B ed. Pain measurement in man: neurophysiological correlates of pain. Amsterdam: Elsevier, 1984: 409-30.
100. Jollife I. Principal component analysis. New York: Springer-Verlag, 1986.
101. Hunt E. Mathematical methods of the event-related potentials. Psychophysiology 1985; 22: 395-402.
102. Guthrie D. Intergroup and intrasubject principal component analysis of event related potentials. Psychophysiology 1990; 27: 111-19.
103. Möcks J, Verleger R. Multivariate methods in biosignal analysis: application of principal component analysis to event-related potentials. In: Weikunat R ed. Digital biosignal processing. Amsterdam: Elsevier, 1991: 399-458.
104. May JG, Dunlap WP, Lovegrove WL. Factor scores derived from visual evoked potential latencies differentiate good and poor readers. Clin Vision Sci 1992; 7: 67-70.
105. Kaiser HF. Computer program for various rotation in factor analysis. Educ Psychol Meas 1998; 19: 413-20.
106. Donchin E, Heffley EF. Multivariate analysis of event-related potential data: a tutorial review. In: Otto DA ed. Multidisciplinary perspectives in event-related brain potential research, EPA-600/9-77-043. Washington: US Government Printing Office, 1978: 555-72.
107. Chapman RM, McCrary JW. EP component identification and measurement by principal components analysis. Brain Cogn 1995; 27: 288-10.
108. Sen A, Srivasta M. Regression analysis. New York: Springer-Verlag, 1990.
109. McGillem CD, Aunon JL. Analysis of event-related potentials. In: Gevins A, Rémond A eds. Handbook of electroencephalography and clinical neurophysiology, vol. 1. Amsterdam: Elsevier, 1987: 131-69.
110. Scharein E, Häger F, Bromm B. Spectral estimators of short EEG segments. In: Bromm B ed. Pain measurement in man: neurophysiological correlates of pain. Amsterdam: Elsevier, 1984: 189-202.
111. Marple S. Digital spectral analysis. London: Prentice-Hall, 1987.
112. Bromm B, Herrmann WM, Scharein E. Zwei Effektive analgetika im Wirkungsvergleich. Fortschr Med 1989; 107: 385-89.
113. Cattel R. The Scree test for the number of factors. Multivariate Behav Res 1966; 1: 245-76.
114. Bromm B, Meier W, Scharein E. Antagonism between tilidine and naloxone on cerebral potentials and pain ratings in man. Eur J Pharmacol 1983; 87: 431-39.
115. Bromm B, Scharein E. Factors differentiating between analgesia and sedation in spontaneous and evoked EEG [Abstract]. Soc Neurosci Abstr 1992; 18(1): 201.
116. Scharein E. Schmerzrelevante cerebrale Potentiale: Statistische Identifikation und experimentelle Validierung. Hamburg: Habilitationsschrift, 1997.
117. Inturrisis C, Foley K. Narcotic analgesics in the management of pain. In: Kuhar M, Pasternak G eds. Analgesics: neurochemical, behavioral, and chemical perspectives. New York: Raven, 1984: 257-88.
118. Saarialho-Kere U, Mattila MJ, Seppaelae T. Pentazocine and codeine: effects on human performance and mood and interactions with diazepam. Med Biol 1986; 64: 293-99.
119. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol) 1971; 231: 232-35.
120. Smith JB, Willis AL. Aspirin selectively inhibits prostaglandin production in human platelets. Nature (New Biol) 1971; 231: 235-37.
121. Ferreira SH, Lorenzetti BB, Correa FMA. Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol 1978; 53: 39-48.
122. Flower RJ, Moncada S, Vane JR. Drug therapy of inflammation. Analgesic-antipyretics and anti-inflammatory agents; drugs employed in the treatment of gout. In: Goodman Gilman A, Goodman LS, Rall TW, Murad F eds. Goodman and Gilman's the pharmacological basis of therapeutics, seventh edition. New York: Macmillan, 1985: 674-715.
123. Yaksh TL. Central and peripheral mechanisms for the antialgesic action of acetylsalicylic acid. In: Barnett HJM, Hirsh J, Mustard JF eds. Acetylsalicylic acid: new aspects for an old drug. New York: Raven, 1982: 137-51.
124. Shyu KW, Lin MT, Wu TC. Possible role of central serotoninergic neurons in the development of dental pain and aspirin-induced analgesia in the monkey. Exp Neurol 1984; 84: 179-87.
125. Brune K, Beck WS, Geisslinger G, Menzel-Soglowek S, Peskar BM, Peskar BA. Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experientia 1991; 47: 257-61.
126. Jurna I, Yaksh TT eds. Central mechanisms for analgesia by acetylsalicylic acid and [functionally] related componds. Progr Pharmacol Clin Pharmacol 1993; 10: 1-197.
127. Bromm B, Rundshagen I, Scharein E. Central effects of acetylsalicylic acid in healthy men. Arzneimitteforschung/Drug Res 1991; 41: 1123-29.
128. Bromm B, Forth W, Richter E, Scharein E. Effects of acetaminophen and antipyrine on non-inflammatory pain and EEG activity. Pain 1992; 50: 213-21.
129. Cooper SA. Comparative analgesic efficacies of aspirin and acetaminophen. Arch Intern Med 1981; 141: 282-85.
130. Jackson CH, MacDonald NC, Cornett JWD. Acetaminophen. Can Med Assoc 1984; 131: 25-37.
131. Brune K. Is there a rational basis for the different spectra of adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs)? Drugs 1990; 40 (Suppl 5): 12-15.
132. Bromm B, Scharein E. Alterations in the human EEG induced by acetylsalicylic acid and related drugs. Progr Pharmacol Clin Pharmacol 1993; 10: 23-40.
133. Lim RKS. Pain. Annu Rev Physiol 1970; 32: 269-88.
134. Hill HF, Chapman CR, Seager LS et al. Steadystate infusions of opioids in humans. II: Concentration-effect relationships and therapeutic margins. Pain 1990; 43: 69-79.
135. Mather LE. Pharmacokinetic and pharmacodynamic profiles of opioid analgesics: a sameness amongst equals [Editorial]? Pain 1990; 43: 3-6.
136. Inturrisi CE. Pharmacokinetic considerations in analgesic study design. In: Max MB, Portenoy RK, Laska EM eds. The design of analgesic clinical trials (Advances in pain research and therapy, vol. 18). New York: Raven Press, 1991: 559-562.
137. Max MB, Byas-Smith MG, Gracely RH, Bennett GJ. Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin Neuropharmacol 1995; 18: 360-68.
138. Wolff T, Samuelsson H, Hedner T. Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration. Pain 1995; 62: 147-54.
139. Thürauf N, Fleischer WK, Liefhold J, Schmid O, Kobal G. Dose dependent time course of the analgesic effect of a sustained-release preparation of tramadol on experimental phasic and tonic pain. Br J Clin Pharmacol 1996; 41: 115-23.
140. World Health Organization. Cancer pain relief. Geneva: WHO, 1986.
141. Bromm B. Algesimetry by EEG and MEG: liquor concentrations and pain relief. In: Krijzer F, Herrmann WM eds. Advances in pharmaco-EEG: practical and theoretical considerations in preclinical and clinical studies. Berlin: International Pharmaco-EEG Group, Free University of Berlin, 1999: 147-73.
142. Hennies HH, Friderichs E, Schneider J. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung 1988; 38: 877-80.
143. Raffa RB, Friderichs E, Reimann W et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 1992; 260: 275-85.
144. Becker R, Lintz W. Determination of tramadol in human serum by capillary gas chromatography with nitrogen-selective detection. J Chromatogr 1996; 377: 213-20.
145. Vollmer K-O, Thomann P, Hengy H. Pharmacokinetics of tilidine and metabolites in man. Arzneimittelforschung/Drug Res 1989; 39: 1283-88.
146. Albinus M, Hempelmann G. Analgetika und Schmerztherapie. Stuttgart: Wissenschaftliche Versuchsgesellschaft, 1988.
147. Herrmann M. Zum Wirkungsprinzip der Kombination Tilidin plus Naloxon. In: Keup W ed. Biologie der Sucht. Berlin: Springer-Verlag, 1984: 201-16.
148. Austin TR. Ketamine-hydrochloride: a potent analgesic. BMJ 1976; ii: 943-46.
149. Clemens JA, Nimmo WS. Pharmacokinetics and analgesic effects of ketamine in man. Br J Anaesth 1981; 53: 234-39.
150. White PF, Way WL, Trevor AJ. Ketamine: its pharmacology and therapeutic uses. Anaesthesiology 1982; 56: 119-36.
151. Geisslinger G, Hering W, Kamp H-D, Vollmers K-O. Pharmacokinetics of ketamine enantiomers. Br J Anaesth 1995; 75: 506-507.
152. Marshall BE, Wollmann H. General anesthetics. In: Goodman Gilman A, Goodman LS, Rall TW, Murad F eds. Goodman and Gilman's the pharmacological basis of therapeutics, seventh edition. New York: Macmillan, 1985: 276-99.
153. Schwarz MS, Virden S, Scotte DF. Effects of ketamine on the electroencephalogram. Anaesthesia 1974; 29: 135-40.
154. Tasuno J, Kawakami Y, Susuki H, Fujita M. Ketamine induced changes in the electroencephalogram (EEG), investigated by two-dimensional maps. In: Domino EF ed. Status of ketamine in anesthesiology. Ann Arbor: NPP Books, 1990: 167-80.
155. Bromm B, Kohlhoff H, Scharein E, Bischoff P, Schulte am Esch J. Cerebral structures involved in unconsciousness and analgesia: EEG and MEG analyses under ketamine [Abstract]. J Neurol Sci 1997; 160: 30.
156. Bromm B, Scharein E, Kochs E, Schulte am Esch J. Dissociation of analgesia and anesthesia under ketamine. In: Gebhart GF, Hammond DL, Jensen TS eds. Proceedings of the 7th World Congress on Pain (Progress in pain research and management, vol. 2); 1993 Aug 22-27; Paris. Seattle: IASP Press, 1994: 657-67.
157. Kochs E, Scharein E, Treede R, Bromm B. Analgesic efficacy of low-dose ketamine. Anesthesiology 1996; 85: 304-14.
158. Bromm B, Meier W, Scharein E. Pre-stimulus/ post-stimulus relations in EEG spectra and their modulations by an opioid and an antidepressant. Electroencephalogr Clin Neurophysiol 1989; 73: 188-97.
159. Bromm B, Meier W, Scharein E. Imipramine reduces experimental pain. Pain 1986; 25: 245-57.
160. Bromm B, Ganzel R, Herrmann WM, Meier W, Scharein E. Pentazocin and flupirtine effects on spontaneous and evoked EEG activity. Neuropsychobiology 1986; 16: 152-56.
161. Handwerker HO. Electrophysiological mechanisms in inflammatory pain. Agents Actions 1991; 32 (Suppl): 91-99.
162. Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs 1996; 52: 13-23.
163. Bromm B, Hermann MW, Scharein E. The analgesic efficacy of paracetamol and acetylsalicyclic acid in the experimental pain model. Schmerz Pain Douleur 1988; 9: 5-11.
164. Bromm B, Rundshagen I, Scharein E. Kombinationspräparate auf dem Prüfstand: Paracetamol plus Acetylsalisylsäure. Pharmazeutische Zeitung 1989; 20: 26-34.